The global PD-1 and PD-L1 inhibitors market was valued at approximately USD 54.90 Billion in 2024, propelled by the rising incidence of cancer worldwide. The market is expected to grow at a robust CAGR of 16.10% from 2025 to 2034, reaching an estimated value of USD 244.28 Billion by 2034. https://www.expertmarketresearch.com/reports/pd-1-and-pd-l1-inhibitors-market